Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA/CMS Info Sharing Could Lead To Quicker Reimbursement Decisions, McClellan Says

This article was originally published in The Pink Sheet Daily

Executive Summary

CMS Administrator McClellan cites drug-eluting stents as an example of a new technology that received reimbursement immediately following product approval as a result of cooperation between the two agencies.
Advertisement

Related Content

FDA/CMS Formal Collaboration Will Include Data Sharing, Parallel Review
FDA/CMS Formal Collaboration Will Include Data Sharing, Parallel Review
McClellan To Head Medicare Rx Law Implementation: Will Greater FDA/CMS Cooperation Ensue?
McClellan To Head Medicare Rx Law Implementation: Will Greater FDA/CMS Cooperation Ensue?

Topics

Advertisement
UsernamePublicRestriction

Register

PS059130

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel